TGFB1 and diabetic cardiomyopathy: In diabetic cardiomyopathy, it reduces collagen overproduction and ECM deposition in cardiac fibroblasts via coordinated inhibition of TGF-β1/Smad, ERK, and p38 MAPK pathways [79].